Skip to main content

Innovation1 Biotech Inc. — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)
$0
Net Income/Loss (FY2023)
-$6.0M
Total Assets (FY2023)
$76.0K
Total Equity (FY2023)
-$3.4M
Cash Flows from Operating Activities (FY2023)
-$620.2K

Source: Innovation1 Biotech Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Discover Hub-Equity